These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 36894968)
41. Concurrent drug use among methadone maintenance patients in mountainous areas in northern Vietnam. Tran BX; Boggiano VL; Thi Nguyen HL; Nguyen LH; Nguyen HV; Hoang CD; Le HT; Tran TD; Le HQ; Latkin CA; Thi Vu TM; Zhang MW; Ho RC BMJ Open; 2018 Mar; 8(3):e015875. PubMed ID: 29567839 [TBL] [Abstract][Full Text] [Related]
42. A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being. Cooperman NA; Hanley AW; Kline A; Garland EL J Subst Abuse Treat; 2021 Aug; 127():108468. PubMed ID: 34134880 [TBL] [Abstract][Full Text] [Related]
43. "The idea is to help people achieve greater success and liberty": A qualitative study of expanded methadone take-home access in opioid use disorder treatment. Suen LW; Castellanos S; Joshi N; Satterwhite S; Knight KR Subst Abus; 2022; 43(1):1143-1150. PubMed ID: 35499469 [No Abstract] [Full Text] [Related]
44. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management. Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331 [TBL] [Abstract][Full Text] [Related]
45. Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine. Meteliuk A; Galvez de Leon SJ; Madden LM; Pykalo I; Fomenko T; Filippovych M; Farnum SO; Dvoryak S; Islam ZM; Altice FL J Subst Abuse Treat; 2021 Feb; 121():108164. PubMed ID: 33191004 [TBL] [Abstract][Full Text] [Related]
46. The role of the Chinese police in methadone maintenance therapy: a literature review. Meng J; Burris S Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719 [TBL] [Abstract][Full Text] [Related]
47. Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients' and prescribers' experiences with changes in unsupervised dosing. Corace K; Suschinsky K; Wyman J; Leece P; Cragg S; Konefal S; Pana P; Barrass S; Porath A; Hutton B Int J Drug Policy; 2022 Apr; 102():103573. PubMed ID: 35123246 [TBL] [Abstract][Full Text] [Related]
48. State guidance and system changes related to COVID-19: Impact on opioid treatment programs. Fuller DB; Gryczynski J; Schwartz RP; Halsted C; Mitchell SG; Whitter M J Subst Use Addict Treat; 2024 Mar; 158():209214. PubMed ID: 38042301 [TBL] [Abstract][Full Text] [Related]
49. Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives. Hatch-Maillette MA; Peavy KM; Tsui JI; Banta-Green CJ; Woolworth S; Grekin P J Subst Abuse Treat; 2021 May; 124():108223. PubMed ID: 33342667 [TBL] [Abstract][Full Text] [Related]
50. Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism. Westerberg VS; McCrady BS; Owens M; Guerin P J Subst Abuse Treat; 2016 Nov; 70():1-6. PubMed ID: 27692182 [TBL] [Abstract][Full Text] [Related]
52. Loneliness and Illicit Opioid Use Among Methadone Maintenance Treatment Patients. Polenick CA; Cotton BP; Bryson WC; Birditt KS Subst Use Misuse; 2019; 54(13):2089-2098. PubMed ID: 31232142 [No Abstract] [Full Text] [Related]
53. Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care? Trujols J; Larrabeiti A; Sànchez O; Madrid M; De Andrés S; Duran-Sindreu S J Subst Abuse Treat; 2020 Dec; 119():108154. PubMed ID: 33032860 [TBL] [Abstract][Full Text] [Related]
54. Supervised dosing with a long-acting opioid medication in the management of opioid dependence. Saulle R; Vecchi S; Gowing L Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766 [TBL] [Abstract][Full Text] [Related]
55. Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China. Li ZB; Zhang L; Wang J; Huang LP; Zhou ZR; Cao YN; Zhao M; Du J Harm Reduct J; 2017 Nov; 14(1):71. PubMed ID: 29096647 [TBL] [Abstract][Full Text] [Related]
56. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Yin W; Pang L; Cao X; McGoogan JM; Liu M; Zhang C; Li Z; Li J; Rou K Addiction; 2015 Jan; 110 Suppl 1():51-60. PubMed ID: 25533864 [TBL] [Abstract][Full Text] [Related]
57. Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions. Bouck Z; Scheim AI; Gomes T; Ling V; Caudarella A; Werb D Int J Drug Policy; 2022 Jun; 104():103680. PubMed ID: 35447476 [TBL] [Abstract][Full Text] [Related]